✦ LIBER ✦

Characterization of skin pathology in non–small cell lung cancer patients treated with the EGFR tyrosine kinase inhibitor erlotinib

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Accuracy of RECIST 1.1 for non-small cel

✍ Sun, Jong-Mu; Ahn, Myung-Ju; Park, Min Jae; Yi, Jun Ho; Kim, Tae Sung; Chung, My 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 126 KB

First-line treatment of EGFR-mutant non-

✍ Neal, Joel; Nguyen, Kim-Son H. 📂 Article 📅 2012 🏛 Dove Press Ltd. 🌐 English ⚖ 228 KB

Plasma MIP-1β levels and skin toxicity i

✍ Kimura, Hideharu; Kasahara, Kazuo; Sekijima, Masaru; Tamura, Tomohide; Nishio, K 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Volumetric tumor growth in advanced non-

✍ Nishino, Mizuki; Dahlberg, Suzanne E.; Cardarella, Stephanie; Jackman, David M.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

Disease Flare After EGFR Tyrosine Kinase

✍ Hua-Jun Chen, Hong-Hong Yan, Jin-Ji Yang, Zhi-Hong Chen… 📂 Article 📅 2013 🏛 Springer Netherlands 🌐 English ⚖ 214 KB

Efficacy of EGFR Tyrosine Kinase Inhibit

✍ Fausto Petrelli; Karen Borgonovo; Mary Cabiddu; Sandro Barni 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 473 KB